eXoZymes, Inc.
EXOZ
$6.17
-$0.14-2.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 19.72% | -20.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.75% | -11.45% | |||
| Operating Income | -23.75% | 11.45% | |||
| Income Before Tax | -21.45% | 14.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.45% | 10.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.45% | 10.73% | |||
| EBIT | -23.75% | 11.45% | |||
| EBITDA | -24.39% | 11.79% | |||
| EPS Basic | -18.63% | 11.41% | |||
| Normalized Basic EPS | -18.62% | 14.79% | |||
| EPS Diluted | -18.63% | 11.41% | |||
| Normalized Diluted EPS | -18.62% | 14.79% | |||
| Average Basic Shares Outstanding | 2.38% | 0.78% | |||
| Average Diluted Shares Outstanding | 2.38% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||